Antimicrobial treatment of Morganella morganii invasive infections: Systematic review
RZ Zaric, S Jankovic, M Zaric, M Milosavljevic… - Indian journal of medical …, 2021 - Elsevier
Background Morganella morganii is a Gram-negative, rod-shaped, facultative anaerobic
bacillus divided into two subspecies, morganii and sibonii. Previously classified as Proteus …
bacillus divided into two subspecies, morganii and sibonii. Previously classified as Proteus …
Performance and impact of a multiplex PCR in ICU patients with ventilator-associated pneumonia or ventilated hospital-acquired pneumonia
N Peiffer-Smadja, L Bouadma, V Mathy, K Allouche… - Critical care, 2020 - Springer
Background Early appropriate antibiotic therapy reduces morbidity and mortality of severe
pneumonia. However, the emergence of bacterial resistance requires the earliest use of …
pneumonia. However, the emergence of bacterial resistance requires the earliest use of …
[HTML][HTML] Surging bloodstream infections and antimicrobial resistance during the first wave of COVID–19: a study in a large multihospital institution in the Paris region
R Amarsy, D Trystram, E Cambau, C Monteil… - International Journal of …, 2022 - Elsevier
Objectives This study measured the impact of the first wave of COVID-19 pandemic (COVID-
19)(March–April 2020) on the incidence of bloodstream infections (BSIs) at Assistance …
19)(March–April 2020) on the incidence of bloodstream infections (BSIs) at Assistance …
Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections caused by AmpC β-lactamase–producing Enterobacter spp, Citrobacter …
Background Carbapenems are recommended treatment for serious infections caused by
AmpC-producing gram-negative bacteria but can select for carbapenem resistance …
AmpC-producing gram-negative bacteria but can select for carbapenem resistance …
[HTML][HTML] Clinical approach to nosocomial bacterial sepsis
P Reddy - Cureus, 2022 - ncbi.nlm.nih.gov
Bacterial sepsis and septic shock are associated with a high mortality, and when clinically
suspected, clinicians must initiate broad-spectrum antimicrobials within the first hour of …
suspected, clinicians must initiate broad-spectrum antimicrobials within the first hour of …
Morganella morganii, an emerging cause of bloodstream infections
KB Laupland, DL Paterson, F Edwards… - Microbiology …, 2022 - Am Soc Microbiol
Although recent reports of extensively antibiotic-resistant strains have highlighted the
importance of Morganella morganii as an emerging pathogen, the epidemiology of serious …
importance of Morganella morganii as an emerging pathogen, the epidemiology of serious …
Effectiveness of third-generation cephalosporins or piperacillin compared with cefepime or carbapenems for severe infections caused by wild-type AmpC β-lactamase …
A Maillard, T Delory, J Bernier, A Villa, K Chaibi… - International Journal of …, 2023 - Elsevier
Background The optimal treatment regimen for infections caused by wild-type AmpC β-
lactamase-producing Enterobacterales remains controversial. This study compared the …
lactamase-producing Enterobacterales remains controversial. This study compared the …
[HTML][HTML] Enterobacterales carrying chromosomal AmpC β-lactamases in Europe (EuESCPM): epidemiology and antimicrobial resistance burden from a cohort of 27 …
M Boattini, G Bianco, LI Llorente, LA Acero… - International Journal of …, 2024 - Elsevier
Abstract Introduction The ESCPM group (Enterobacter species including Klebsiella
aerogenes-formerly Enterobacter aerogenes, Serratia species, Citrobacter freundii complex …
aerogenes-formerly Enterobacter aerogenes, Serratia species, Citrobacter freundii complex …
Wide Distribution and Specific Resistance Pattern to Third-Generation Cephalosporins of Enterobacter cloacae Complex Members in Humans and in the …
Species belonging to Enterobacter cloacae complex have been isolated in numerous
environments and samples of various origins. They are also involved in opportunistic …
environments and samples of various origins. They are also involved in opportunistic …
Clinical outcome of wild-type AmpC-producing Enterobacterales infection in critically ill patients treated with β-lactams: A prospective multicenter study
R Mounier, R Le Guen, PL Woerther, M Nacher… - Annals of Intensive …, 2022 - Springer
Background β-lactams are the main antibiotics used against wild-type AmpC-producing
Enterobacterales (wtAE). However, they may fail or select AmpC-overproducing mutants …
Enterobacterales (wtAE). However, they may fail or select AmpC-overproducing mutants …